Kunihiko Tamaki

Kunihiko Tamaki's AcademicInfluence.com Rankings

Kunihiko Tamaki

Philosophy

#6403

World Rank

#9437

Historical Rank

Logic

#3577

World Rank

#4764

Historical Rank

philosophy Degrees

Kunihiko Tamaki

Biology

#8725

World Rank

#11850

Historical Rank

Cell Biology

#352

World Rank

#362

Historical Rank

Immunology

#504

World Rank

#521

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Kunihiko Tamaki's Degrees

PhD Immunology University of Tokyo
Doctorate Medicine University of Tokyo

Why Is Kunihiko Tamaki Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Kunihiko Tamaki's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Epidermal Langerhans cells are derived from cells originating in bone marrow (1979) (915)
Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. (2001) (492)
Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. (1999) (420)
Characterization of SIS3, a Novel Specific Inhibitor of Smad3, and Its Effect on Transforming Growth Factor-β1-Induced Extracellular Matrix Expression (2006) (400)
Origin and Function of Epidermal Langerhans Cells (1980) (399)
Regulatory B Cells (B10 Cells) Have a Suppressive Role in Murine Lupus: CD19 and B10 Cell Deficiency Exacerbates Systemic Autoimmunity (2010) (299)
Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. (2006) (243)
Estrogen enhances immunoglobulin production by human PBMCs. (1999) (241)
Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. (2004) (212)
A randomized double-blind trial of intravenous immunoglobulin for pemphigus. (2009) (209)
Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells (1996) (200)
Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan. (2004) (199)
Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. (1999) (195)
Increased Expression of Integrin αvβ3 Contributes to the Establishment of Autocrine TGF-β Signaling in Scleroderma Fibroblasts1 (2005) (195)
Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. (2002) (192)
B7‐1 expression of Langerhans cells is up‐regulated by proinflammatory cytokines, and is down‐regulated by interferon‐γ or by interleukin‐10 (1995) (185)
Ia antigens in mouse skin are predominantly expressed on Langerhans cells. (1979) (184)
Blockade of endogenous transforming growth factor β signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: Association with increased expression of transforming growth factor β receptors (2001) (180)
Mechanical stretching in vitro regulates signal transduction pathways and cellular proliferation in human epidermal keratinocytes. (2004) (162)
Serum macrophage‐derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis (2002) (147)
Increased Expression of Integrin αvβ5 Induces the Myofibroblastic Differentiation of Dermal Fibroblasts (2006) (146)
Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. (2003) (143)
CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes. (2003) (140)
Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. (2003) (139)
Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. (2009) (138)
Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. (1997) (131)
LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis. (2010) (122)
Tenascin-C upregulation by transforming growth factor-β in human dermal fibroblasts involves Smad3, Sp1, and Ets1 (2004) (121)
Involvement of αvβ5 integrin–mediated activation of latent transforming growth factor β1 in autocrine transforming growth factor β signaling in systemic sclerosis fibroblasts (2005) (116)
CD19 expression in B cells is important for suppression of contact hypersensitivity. (2007) (115)
Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. (2005) (114)
Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts. (1997) (103)
CC chemokine receptor 4 expression on peripheral blood CD4+ T cells reflects disease activity of atopic dermatitis. (2001) (101)
Growth regulation in scleroderma fibroblasts: increased response to transforming growth factor-beta 1. (1995) (101)
Characterization and Localization of Side Population Cells in Mouse Skin (2005) (100)
Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts. (1998) (100)
Elevated levels of eotaxin and interleukin‐5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia (2000) (99)
Significant elevation of serum levels of eotaxin‐3/CCL26, but not of eotaxin‐2/CCL24, in patients with atopic dermatitis: serum eotaxin‐3/CCL26 levels reflect the disease activity of atopic dermatitis (2003) (99)
Induction of tolerance to topically applied TNCB using TNP-conjugated ultraviolet light-irradiated epidermal cells. (1981) (98)
Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells. (2004) (96)
Antagonistic Effects of TNF-α on TGF-β Signaling Through Down-Regulation of TGF-β Receptor Type II in Human Dermal Fibroblasts1 (2003) (96)
Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. (2001) (95)
The Repeat Domain of the Melanosomal Matrix Protein PMEL17/GP100 Is Required for the Formation of Organellar Fibers* (2006) (94)
Possible roles of IL-27 in the pathogenesis of psoriasis. (2010) (92)
Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis (2000) (91)
Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133. (2007) (90)
IL-4 Up-Regulates the Expression of Tissue Inhibitor of Metalloproteinase-2 in Dermal Fibroblasts Via the p38 Mitogen-Activated Protein Kinase-Dependent Pathway1 (2002) (88)
B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse. (2004) (88)
Interleukin‐4 and interleukin‐13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells (2005) (88)
Inflammatory Versus Proliferative Processes in Epidermis (2000) (88)
Interleukin-13 Stimulates the Transcription of the Human α2(I) Collagen Gene in Human Dermal Fibroblasts* (2004) (87)
Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome‐specific and proteolytically released protein (2010) (86)
Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts. (2006) (86)
Phosphatidylinositol 3-Kinase Is Involved in α2(I) Collagen Gene Expression in Normal and Scleroderma Fibroblasts1 (2004) (85)
The role of epidermal cells in the induction and suppression of contact sensitivity. (1981) (84)
Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. (2000) (84)
Regulation of fibrogenic/fibrolytic genes by platelet‐derived growth factor C, a novel growth factor, in human dermal fibroblasts (2005) (84)
Up-regulated expression of transforming growth factor beta receptors in dermal fibroblasts in skin sections from patients with localized scleroderma. (2001) (82)
Serum KL-6 in adult patients with polymyositis and dermatomyositis. (2000) (81)
Tacrolimus concentrations in blood during topical treatment of atopic dermatitis (1996) (81)
Involvement of αvβ5 Integrin in the Establishment of Autocrine TGF-β Signaling in Dermal Fibroblasts Derived from Localized Scleroderma (2006) (79)
Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. (2002) (79)
Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. (2008) (79)
Skin manifestations of arsenicosis in two villages in Bangladesh (2002) (78)
Serum high molecular weight adiponectin levels are decreased in psoriasis patients. (2009) (78)
Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis. (1995) (75)
P2Y6 Receptor Signaling Pathway Mediates Inflammatory Responses Induced by Monosodium Urate Crystals (2012) (75)
Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma. (2010) (75)
Japanese guideline for atopic dermatitis. (2011) (75)
Prevalence of atopic dermatitis in Japanese elementary schoolchildren (2005) (73)
Differential effects of cytokines and immunosuppressive drugs on CD40, B7-1, and B7-2 expression on purified epidermal Langerhans cells1. (1999) (72)
Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells. (2005) (72)
Increased serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis. (1998) (71)
Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts. (2005) (70)
Prevalence of atopic dermatitis determined by clinical examination in Japanese adults (2006) (70)
Increased Expression Levels of Integrin αvβ5 on Scleroderma Fibroblasts (2004) (70)
Selective regulation of ICAM‐1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells (1994) (69)
Serum measurement of thymus and activation‐regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age‐specific analysis in atopic dermatitis (2009) (68)
Oncostatin M Stimulates the Growth of Dermal Fibroblasts Via a Mitogen-Activated Protein Kinase-Dependent Pathway1 (2000) (68)
Clinical and laboratory features of scleroderma patients with pulmonary hypertension. (2000) (67)
Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans (2004) (65)
Interleukin 15 induces the signals of epidermal proliferation through ERK and PI 3-kinase in a human epidermal keratinocyte cell line, HaCaT. (2003) (65)
Connective tissue growth factor is directly related to liver fibrosis. (2002) (64)
Epidemiological Analysis of Prognosis of 496 Japanese Patients with Progressive Systemic Sclerosis (SSc) (1996) (64)
Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts. (2005) (64)
The origin of Langerhans cells. (1980) (64)
Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors. (2001) (64)
Constitutive phosphorylation of focal adhesion kinase is involved in the myofibroblast differentiation of scleroderma fibroblasts. (2005) (62)
Relationship between steatocystoma multiplex and eruptive vellus hair cysts. (1992) (62)
Early inflammatory changes in the "perilesional skin" of psoriatic plaques: is there interaction between dendritic cells and keratinocytes? (2007) (62)
Characterization of a Mouse Second Leukotriene B4 Receptor, mBLT2 (2005) (61)
CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells. (2007) (61)
Clinical and laboratory features of scleroderma patients developing skeletal myopathy (2005) (61)
Ultrasound measurement of skin thickness in systemic sclerosis. (1995) (61)
Granulocyte/Macrophage Colony-Stimulating Factor Inhibits IL-12 production of Mouse Langerhans Cells (2000) (61)
Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease. (2002) (60)
Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts. (2002) (59)
High level of thymus and activation‐regulated chemokine in blister fluid and sera of patients with bullous pemphigoid (2003) (59)
Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis. (2006) (58)
Anti–α-Fodrin Antibodies in Sjögren Syndrome and Lupus Erythematosus (1999) (57)
Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. (2005) (57)
Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris (2006) (57)
Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma. (2000) (56)
Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene. (2000) (55)
Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis. (2002) (55)
CD22 Expression Mediates the Regulatory Functions of Peritoneal B-1a Cells during the Remission Phase of Contact Hypersensitivity Reactions (2010) (55)
Polymorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulgaris. (2002) (54)
Treatment of 153 Japanese patients with Q-switched alexandrite laser (2007) (54)
Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-α and IL-4 and downregulated by IFN-γ (2003) (54)
Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts. (2006) (53)
Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis. (2000) (52)
Dermatoscopic and videomicroscopic features of melanocytic plantar nevi. (1996) (51)
CCL17 transgenic mice show an enhanced Th2‐type response to both allergic and non‐allergic stimuli (2006) (51)
Characterization of Mouse Cysteinyl Leukotriene Receptors mCysLT1 and mCysLT2 (2002) (50)
Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1 (2005) (50)
Prolactin enhances basal and IL‐17‐induced CCL20 production by human keratinocytes (2009) (50)
Serum concentrations of basic fibroblast growth factor in collagen diseases. (1996) (49)
Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma. (2006) (48)
Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts. (2005) (48)
Increased phosphorylation and activation of mitogen-activated protein kinase p38 in scleroderma fibroblasts. (2005) (48)
Demonstration of TARC and CCR4 mRNA Expression and Distribution Using In situ RT‐PCR in the Lesional Skin of Atopic Dermatitis (2003) (48)
Evaluation of the treatment of port-wine stains with the 595-nm long pulsed dye laser: a large prospective study in adult Japanese patients. (2006) (47)
Decreased ET(B) receptor expression in human metastatic melanoma cells. (1996) (47)
Successful treatment of pigmented purpuric dermatosis with griseoiulvin (1995) (46)
Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts. (2003) (45)
Serum levels of tissue inhibitor of metalloproteinase‐1 and 2 in patients with eosinophilic fasciitis (2004) (45)
Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines. (1997) (45)
Both IL-4 and IL-13 inhibit the TNF-α and IFN-γ enhanced MDC production in a human keratinocyte cell line, HaCaT cells (2003) (44)
Serum chemokine profiles in patients with alopecia areata (2007) (44)
Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease. (2000) (44)
The effect of neuropeptides/hormones on Langerhans cells. (1999) (43)
An Open Trial of Oral Macrolide Treatment for Psoriasis Vulgaris (2000) (43)
Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis (1997) (43)
Human herpesvirus 7 and pityriasis rosea. (1999) (43)
Antibodies to molluscum contagiosum virus in the general population and susceptible patients. (2000) (42)
Ontogeny of Langerhans cells. (1980) (42)
α2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts (2005) (42)
Up-regulation of CD44 expression by tumor necrosis factor-alpha is neutralized by interleukin-10 in Langerhans cells. (1995) (42)
Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer. (1986) (42)
The secreted form of a melanocyte membrane‐bound glycoprotein (Pmel17/gp100) is released by ectodomain shedding (2010) (41)
Serum carcinoembryonic antigen level in Paget's disease (1984) (40)
Interleukins 18 and 12 synergistically upregulate interferon-gamma production by murine dendritic epidermal T cells. (1999) (40)
Epidermal Growth Factor Induces Fibronectin Expression in Human Dermal Fibroblasts via Protein Kinase C δ Signaling Pathway (2004) (39)
Platelet derived growth factor induced tenascin‐C transcription is phosphoinositide 3‐kinase/Akt‐dependent and mediated by Ets family transcription factors (2006) (38)
High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. (1998) (38)
Serum chemokine profile in patients with bullous pemphigoid (2007) (38)
The action of a novel vitamin D3 analogue, OCT, on immunomodulatory function of keratinocytes and lymphocytes (1999) (38)
Lack of Association between the Promoter Polymorphisms at Positions –308 and –238 of the Tumor Necrosis Factor Alpha Gene and Psoriasis vulgaris in Japanese Patients (2004) (37)
B Cell Antigen Receptor and CD40 Differentially Regulate CD22 Tyrosine Phosphorylation1 (2006) (37)
The human histocompatibility leukocyte antigen (HLA) haplotype is associated with the onset of postherpetic neuralgia after herpes zoster (2004) (37)
Langerhans cells exhibit low responsiveness to double-stranded RNA. (2004) (37)
Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis. (1994) (37)
Human keratinocytes express fractalkine/CX3CL1. (2003) (37)
Serum levels of CCL17/TARC in various skin diseases (2006) (37)
Annular erythema associated with lupus erythematosus/Sjögren's syndrome. (1997) (37)
Safe and Effective Treatment of Refractory Facial Lesions in Atopic Dermatitis Using Topical Tacrolimus following Corticosteroid Discontinuation (2001) (36)
Vα24+ natural killer T cells are markedly decreased in atopic dermatitis patients (2003) (36)
Elevated serum CTACK/CCL27 levels in CTCL. (2006) (36)
IL-4, but not IL-13, modulates TARC (thymus and activation-regulated chemokine)/CCL17 and IP-10 (interferon-induced protein of 10kDA)/CXCL10 release by TNF-alpha and IFN-gamma in HaCaT cell line. (2002) (36)
CCL11-CCR3 interactions promote survival of anaplastic large cell lymphoma cells via ERK1/2 activation. (2011) (36)
Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts. (2004) (35)
Cutaneous lupus mucinosis: a review of our cases and the possible pathogenesis (1997) (35)
Plasmacytosis: systemic or cutaneous, are they distinct? (2000) (35)
Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis. (2004) (34)
A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation (2004) (34)
The direct action of 1α,25(OH)2-vitamin D3 on purified mouse Langerhans cells (2007) (34)
The Successful Treatment of Prurigo pigmentosa with Macrolide Antibiotics (2001) (34)
Specificity in stress response: epidermal keratinocytes exhibit specialized UV-responsive signal transduction pathways. (2003) (34)
A case of diffuse scleroderma successfully treated with high-dose intravenous immune globulin infusion. (2005) (34)
Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis vulgaris and bullous pemphigoid. (2005) (33)
Activation of Akt by mechanical stretching in human epidermal keratinocytes (2006) (33)
Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis. (2009) (33)
Penicillamine‐Induced Degenerative Dermatoses: Report of a Case and Brief Review of Such Dermatoses (1997) (33)
Eotaxin gene single nucleotide polymorphisms in the promoter and exon regions are not associated with susceptibility to atopic dermatitis, but two of them in the promoter region are associated with serum IgE levels in patients with atopic dermatitis. (2002) (33)
Treatment of plasma cell cheilitis with griseofulvin. (1994) (33)
Increased numbers of CD68 antigen positive dendritic epidermal cells and upregulation of CLA (cutaneous lymphocyte-associated antigen) expression on these cells in various skin diseases. (1998) (32)
Elevated plasma endothelin levels in systemic sclerosis (2004) (31)
Onychomycosis caused by Fusarium proliferatum (2005) (31)
Interleukin‐1 but not tumour necrosis factor α synergistically upregulates the granulocyte—macrophage colony‐stimulating factor‐induced B7‐1 expression of murine Langerhans cells (1996) (31)
Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritis. (2003) (31)
Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris. (2002) (31)
Anatomical distribution and immunological characteristics of epidermolysis bullosa acquisita antigen and bullous pemphigoid antigen (1986) (31)
Prevalence of atopic dermatitis in Japanese adults and community validation of the U.K. diagnostic criteria. (2009) (31)
Long‐Term Continuous versus Intermittent Cyclosporin: Therapy for Psoriasis (2003) (30)
Variations in the human Th2-specific chemokine TARC gene (2003) (30)
Functional CD40 ligand is expressed on epidermal Langerhans cells (1999) (30)
Prevalence and antigen specificity of anti-histone antibodies in patients with polymyositis/dermatomyositis. (1999) (30)
Role of Langerhans cells in cutaneous protective immunity: is the reappraisal necessary? (2006) (30)
CCR4 and CCR10 are expressed on epidermal keratinocytes and are involved in cutaneous immune reaction. (2008) (30)
Antibodies to Th/To ribonucleoprotein in patients with localized scleroderma. (2001) (30)
High‐dose intravenous immunoglobulin infusion as treatment for diffuse scleroderma (2007) (29)
Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid. (2007) (29)
Type I interferons inhibit maturation and activation of mouse Langerhans cells. (2005) (29)
Upregulation of tenascin-C expression by IL-13 in human dermal fibroblasts via the phosphoinositide 3-kinase/Akt and the protein kinase C signaling pathways. (2006) (29)
IL-17F single nucleotide polymorphism is not associated with psoriasis vulgaris or atopic dermatitis in the Japanese population. (2009) (28)
Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN-gamma. (2003) (28)
The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis. (2003) (28)
Dysregulated expression of transforming growth factor β and its type‐I and type‐II receptors in basal‐cell carcinoma (1997) (27)
Clear Cells of Eccrine Glands in a Patient with Clear Cell Syringoma Associated with Diabetes Mellitus (1993) (27)
Thymus and activation‐regulated chemokine (TARC)/CC chemokine ligand (CCL) 17 accelerates wound healing by enhancing fibroblast migration (2011) (27)
Leukocytoclastic Vasculitis with IgA Deposits in Angioimmunoblastic T Cell Lymphoma (2001) (27)
A case of milia en plaque successfully treated with oral etretinate (2007) (27)
Community validation of the U.K. diagnostic criteria for atopic dermatitis in Japanese elementary schoolchildren. (2007) (26)
Interferon-Gamma-Induced RANTES Production by Human Keratinocytes Is Enhanced by IL-1β, TNF-α, IL-4 and IL-13 and Is Inhibited by Dexamethasone and Tacrolimus (2001) (26)
Histopathological evaluation of halo phenomenon in Spitz nevus. (1995) (26)
Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblasts. (2003) (26)
Epidermal growth factor affects the synthesis and degradation of type I collagen in cultured human dermal fibroblasts. (2006) (26)
Exacerbation of pustulosis palmaris et plantaris after topical application of metals accompanied by elevated levels of leukotriene B4 in pustules. (2000) (26)
Differential effects of LPS and TGF-beta on the production of IL-6 and IL-12 by Langerhans cells, splenic dendritic cells, and macrophages. (2004) (25)
Decrease in circulating autotaxin by oral administration of prednisolone. (2013) (25)
Lymphatic dysfunction impairs antigen-specific immunization, but augments tissue swelling following contact with allergens. (2012) (25)
Competition analysis of the human alpha2(I) collagen promoter using synthetic oligonucleotides. (2000) (25)
Interleukin 12 production by monocytes from patients with psoriasis and its inhibition by ciclosporin A (2006) (25)
CD44 Expression in Normal Human Skin and Skin Tumors (1995) (25)
Clinical features of systemic lupus erythematosus in men. Characteristics of the cutaneous manifestations. (1996) (25)
Plasma plasmin–α2‐plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertension (2003) (24)
CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27 (2006) (24)
Secondary cutaneous oxalosis: cutaneous deposition of calcium oxalate dihydrate after long-term hemodialysis. (1994) (24)
Analysis of the expression of cutaneous lymphocyte-associated antigen on the peripheral blood and cutaneous lymphocytes of alopecia areata patients. (2002) (24)
Anti-alpha-fodrin antibodies in Sjögren syndrome and lupus erythematosus. (1999) (24)
Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta 2-GPI) in systemic sclerosis. (1996) (24)
Lectin‐binding sites in Paget's disease (1985) (23)
Cytokine profile of patients with bullous pemphigoid (1994) (23)
LINEAR AND WHORLED NEVOID HYPERMELANOSIS IN A CHILD WITH CHROMOSOMAL MOSAICISM (1992) (23)
Lichen planus pemphigoides: case report and results of immunofluorescence and immunoelectron microscopic study. (1990) (23)
Hapten specific TNP-reactive cytotoxic effector cells using epidermal cells as targets. (1981) (23)
Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease. (2007) (22)
Angiogenic cytokines in serum and cutaneous lesions of patients with polyarteritis nodosa. (2005) (22)
Colocalization of scavenger receptor in CD68 positive foam cells in verruciform xanthoma. (1995) (22)
Soluble CD4 and CD8 in serum from patients with localized scleroderma (1996) (22)
The −431C>T polymorphism of thymus and activation‐regulated chemokine increases the promoter activity but is not associated with susceptibility to atopic dermatitis in Japanese patients (2004) (22)
Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: A randomized, double‐blind, placebo‐controlled trial (2016) (22)
Interferon-gamma, a strong suppressor of cell proliferation, induces upregulation of keratin K6, one of the inflammatory- and proliferation-associated keratins. (2002) (22)
Eccrine syringofibroadenoma (Mascaro): an immunohistochemical study. (2000) (22)
CC Chemokine Receptor 4 as a Possible Target for Therapy of Atopic Dermatitis. (2002) (21)
Distinctive Dermatoscopic Features of Acral Lentiginous Melanoma in Situ from Plantar Melanocytic Nevi and Their Histopathologic Correlation (1998) (20)
Cidofovir diphosphate inhibits molluscum contagiosum virus DNA polymerase activity. (2008) (20)
CCL27‐transgenic mice show enhanced contact hypers ensitivity to Th2, but not Th1 stimuli (2008) (20)
Erythema annulare centrifugum induced by molluscum contagiosum (1993) (20)
Analysis of the COL17A1 in non-Herlitz junctional epidermolysis bullosa and amelogenesis imperfecta. (2006) (20)
Lichen planus‐like contact dermatitis due to methacrylic acid esters (1996) (20)
Autoantibodies to pyruvate dehydrogenase complex in patients with systemic sclerosis. Possible role of anti-E1 alpha antibody as a serologic indicator for development of primary biliary cirrhosis. (1995) (20)
Prevalence of 52-kd and 60-kd Ro/SS-A autoantibodies in Japanese patients with polymyositis/dermatomyositis. (2002) (20)
High calcium, ATP, and poly(I:C) augment the immune response to β-glucan in normal human epidermal keratinocytes. (2011) (20)
Differential phosphorylation of functional tyrosines in CD19 modulates B‐lymphocyte activation (2010) (20)
Increased serum levels of soluble vascular cell adhesion molecule‐1 and soluble E‐selectin in patients with polymyositis/dermatomyositis (2000) (20)
The expression levels and the differential expression of transforming growth factor‐β receptors in dermatofibroma and dermatofibrosarcoma protuberans (2006) (19)
Pseudoscleroderma associated with cancer (2006) (19)
Expression of cutaneous lymphocyte-associated antigen defined by monoclonal antibody HECA-452 on human Langerhans cells. (1996) (19)
Analysis of gene mutations in three cases of dermatofibrosarcoma protuberans (DFSP): ordinary DFSP, DFSP with fibrosarcomatous lesion (DFSP-FS) and lung metastasis of DFSP-FS. (2003) (19)
Langerhans Cells Do Not Produce Interferon-γ (2003) (19)
Recurrent cutaneous eosinophilic vasculitis presenting as annular urticarial plaques. (2005) (19)
Avascular necrosis of bone in systemic lupus erythematosus. The predictive role of precipitating autoantibodies. (1997) (19)
Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis. (2006) (19)
Generalized Melanosis in Metastatic Malignant Melanoma: The Possible Role of DOPAquinone Metabolites (1998) (18)
Recent Advances on Pathogenesis and Therapies in Systemic Sclerosis (2007) (18)
Cutaneous gamma/delta T‐cell lymphoma treated with retinoid and narrowband ultraviolet B (2009) (18)
Increased serum thymic stromal lymphopoietin levels in patients with cutaneous T cell lymphoma (2009) (18)
Ganglioside GQ1b enhances Ig production by human PBMCs. (1998) (18)
Decreased MMP‐9 activity in the serum of patients with diffuse cutaneous systemic sclerosis (2002) (18)
Pretibial epidermolysis bullosa. Successful therapy with a skin graft. (1986) (18)
Induction and suppression of contact sensitivity to fluorescein isothiocyanate (FITC). (1985) (18)
Japanese Guideline for Atopic Dermatitis (2011) (18)
Semaphorin 7A on keratinocytes induces interleukin-8 production by monocytes. (2011) (18)
Rheumatoid factor isotypes in mixed connective tissue disease (2006) (18)
Differential growth regulation in human melanoma cell lines by TIMP-1 and TIMP-2. (2001) (18)
High-dose intravenous immunoglobulin infusion in polyarteritis nodosa (2006) (18)
CCL27 Is Downregulated by Interferon Gamma via Epidermal Growth Factor Receptor in Normal Human Epidermal Keratinocytes (2014) (18)
Drug-Induced Hypersensitivity Syndrome Associated with Transient Hypogammaglobulinaemia and Increase in Serum IgE Level (2005) (17)
Clinical and laboratory features of Japanese patients with scleroderma and telangiectasia (2009) (17)
Clinical features of scleroderma patients with contracture of phalanges (2007) (17)
Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells. (2003) (17)
Anti-U5 snRNP antibody as a possible serological marker for scleroderma-polymyositis overlap. (2002) (17)
Laser Treatment of 26 Japanese Patients with Mongolian Spots (2008) (17)
Rheumatoid factor isotypes and anti‐agalactosyl IgG antibodies in systemic sclerosis (2004) (17)
Potential regulatory elements of the constitutive up-regulated alpha2(I) collagen gene in scleroderma dermal fibroblasts. (2006) (17)
Necrolytic migratory erythema without glucagonoma in a patient with short bowel syndrome (2006) (17)
A case of dermatomyositis triggered by tegafur. (1997) (17)
Histamine differentially regulates the production of Th1 and Th2 chemokines by keratinocytes through histamine H1 receptor. (2011) (17)
1,25-Dihydroxyvitamin D3 decreases the interferon-gamma (IFN-gamma) induced HLA-DR expression but not intercellular adhesion molecule 1 (ICAM-1) on human keratinocytes. (1990) (17)
Rheumatoid factor isotypes in localized scleroderma (2005) (17)
Colchicine and griseofulvin inhibit VCAM-1 expression on human vascular endothelial cells - evidence for the association of VCAM-1 expression with microtubules. (2001) (17)
Expression of cellular prion-related protein by murine Langerhans cells and keratinocytes. (2002) (17)
Impaired growth response to endothelin-1 in scleroderma fibroblasts. (1995) (17)
Serum thymic stromal lymphopoietin levels are not elevated in patients with atopic dermatitis (2008) (16)
Analysis of GM‐CSF gene polymorphisms (3606T/C and 3928C/T) in Japanese patients with atopic dermatitis (2006) (16)
Analysis of HLA class II and TAP alleles in Japanese patients with psoriasis vulgaris. (1998) (16)
Serum BAFF and APRIL levels in patients with alopecia areata. (2008) (16)
α4β7 Integrin is essential for contact hypersensitivity by regulating migration of T cells to skin. (2010) (16)
Autoantibodies to mitochondrial 2‐oxo‐acid dehydrogenase complexes in localized scleroderma (1996) (16)
Ganglioside GD1b supresses immunoglobulin production by human peripheral blood mononuclear cells. (1999) (16)
Epidermal growth factor induces fibronectin expression in human dermal fibroblasts via protein kinase C delta signaling pathway. (2004) (16)
Kimura's disease associated with ulcerative colitis: detection of IL-5 mRNA expression of peripheral blood mononuclear cells and colon lesion. (1998) (16)
Griseofulvin has a potential to modulate the expression of cell adhesion molecules on leukocytes and vascular endothelial cells. (2001) (16)
Detection of antiribosomal P protein antibodies in patients with systemic sclerosis. (1995) (15)
High‐Frequency Ultrasound as a Useful Device in the Preliminary Differentiation of Lichen Sclerosus et Atrophicus from Morphea (2004) (15)
Expression of CC chemokine receptor 3 on human keratinocytes in vivo and in vitro--upregulation by RANTES. (2001) (15)
HNK‐I antibody reacts with peripheral nerves and sweat glands in the skin (1985) (15)
Paronychia: a sign heralding an exacerbation of pemphigus vulgaris. (1993) (15)
TGF-β1-mediated regulation of thymus and activation-regulated chemokine (TARC/CCL17) synthesis and secretion by HaCaT cells co-stimulated with TNF-α and IFN-γ (2002) (15)
Serum levels of matrix metalloproteinase‐13 in patients with eosinophilic fasciitis (2014) (14)
CXCL13 and CCL21 are expressed in ectopic lymphoid follicles in cutaneous lymphoproliferative disorders. (2007) (14)
Multiple Eruptive Dermatofibromas with CD34+ Cells in a Patient with Hypertriglyceridemia (2003) (14)
V alpha 24+ natural killer T cells are markedly decreased in atopic dermatitis patients. (2003) (14)
Interferon-18 gene polymorphism -137 G/C is associated with susceptibility to psoriasis vulgaris but not with atopic dermatitis in Japanese patients. (2009) (14)
Differential effect of griseofulvin on interferon‐γ‐induced HLA‐DR and intercellular adhesion molecule‐1 expression of human keratinocytes (1992) (14)
Mitogenic activity of dermatofibrosarcoma protuberans is mediated via an extracellular signal related kinase dependent pathway. (2002) (14)
Expressions of Various Growth Factors and Their Receptors in Tissues from Neurofibroma (2000) (14)
Treatment of HIV‐associated eosinophilic pustular folliculitis with narrow‐band UVB (2006) (14)
Serum TARC/CCL 17 Levels as a Disease Marker of Atopic Dermatitis (2006) (14)
Bilateral Periorbital Eccrine Hidrocystoma (1994) (14)
Identification and characterization of novel dermal Thy-1 antigen-bearing dendritic cells in murine skin. (1996) (14)
Migration of Langerhans cells in an in vitro organ culture system: IL-6 and TNF-alpha are partially responsible for migration into the epidermis. (1999) (14)
Lack of association of CCR4 single nucleotide polymorphism with atopic dermatitis in Japanese patients. (2004) (14)
A case of peplomycin‐induced scleroderma (2004) (14)
A probable case of Muckle–Wells syndrome (2006) (13)
Cutaneous ciliated cyst on the sole of the foot (1995) (13)
Erythrodermic bullous pemphigoid. (1993) (13)
Anti‐agalactosyl immunoglobulin G antibodies in localized scleroderma (2005) (13)
The role of epidermal cells in the induction of delayed-type hypersensitivity to alloantigens. (1985) (13)
Anti-p53 antibodies in patients with dermatomyositis/polymyositis (2007) (13)
Post‐transplantation chronic graft‐versus‐host disease with overlapping features similar to those of various collagen diseases (2003) (13)
Transforming growth factor‐β up‐regulates CD40‐engaged IL‐12 production of mouse Langerhans cells (2001) (13)
Sclerosing panniculitis is associated with pulmonary hypertension in systemic sclerosis (2005) (13)
Dermatofibrosarcoma protuberans with COL1A1 (exon 18) –PDGFB (exon 2) fusion transcript (2003) (13)
Primary cutaneous anaplastic large cell lymphoma with leg involvement: A case report and review of 11 cases (2011) (13)
Anti-U3 snRNP antibodies in localised scleroderma (2001) (13)
Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts. (2005) (13)
Sézary syndrome treated with narrowband ultraviolet B: time‐course measurement of serum levels of CCL17/CCL27 (2007) (13)
A case of linear scleroderma with muscle calcification (2002) (13)
Does thrombosis cause intravascular fasciitis? (2007) (13)
Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma in a human T-cell leukaemia virus type-1 carrier. (2010) (12)
Serum concentrations of carboxyterminal propeptide of type 1 procollagen and tissue inhibitor of metalloproteinase 1 in patients with dermatomyositis (1998) (12)
Specific inhibition of human skin fibroblast chemotaxis to platelet-derived growth factor A-chain homodimer by transforming growth factor-β1 (2002) (12)
High-concentration (20 mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids. (2002) (12)
Administration of IgG Fraction of Epidermolysis Bullosa Acquisita (EBA) Serum into Mice (1988) (12)
Serum monocyte chemoattractant protein-1 is elevated in lepromatous leprosy patients with high bacterial indices. (2002) (12)
Juvenile pustular psoriasis associated with steroid withdrawal syndrome due to topical corticosteroid (2008) (12)
Altered dynamics of transforming growth factor β (TGF-β) receptors in scleroderma fibroblasts (2010) (12)
Linear and whorled naevoid hypermelanosis: a case with systemic involvement and trisomy 18 mosaicism (2002) (12)
Cytotoxic T lymphocyte antigen-4 gene (CTLA4) polymorphisms in Japanese patients with psoriasis vulgaris. (2003) (12)
Herpetiform pemphigus without anti‐desmoglein 1/3 autoantibodies (2010) (11)
Clinical significance of serum matrix metalloproteinase-13 levels in patients with localized scleroderma. (2006) (11)
Mannose‐Binding Lectin (MBL) Single Nucleotide Polymorphism Is Not Associated with Atopic Dermatitis in Japanese Patients (2005) (11)
Identification of a Novel Marker for Dendritic Cell Maturation, Mouse Transmembrane Protein 123* (2010) (11)
Antipruritic Effect of Macrolide Antibiotics (2000) (11)
Identification and characterization of the low-affinity receptor for immunoglobulin E (FcepsilonRII/CD23) on murine Langerhans cells. (2002) (11)
Serum levels of soluble CD26 in patients with scleroderma. (2008) (11)
Heterogeneity of epidermal Thy-1-positive cells defined by lectin-binding sites. (1986) (11)
Expression and regulation of RANTES/CCL5, MIP-1alpha/CCL3, and MIP-1beta/CCL4 in mouse Langerhans cells. (2004) (11)
Analysis of gene mutations in four cases of dermatofibrosarcoma protuberans (2006) (11)
Linear Connective Tissue Nevus (2007) (11)
Migration of Thy-1+ dendritic epidermal cells (Thy-1+DEC): Ly48 and TNF-alpha are responsible for the migration of Thy-1+DEC to the epidermis. (1994) (11)
High-dose intravenous immunoglobulin infusion in polyarteritis nodosa: report on one case and review of the literature. (2006) (10)
Elevated soluble CD23 levels in the sera from patients with localized scleroderma (1996) (10)
Mucinous carcinoma of the skin could have either an eccrine or an apocrine origin (2004) (10)
A case of subcutaneous nodular fat necrosis with lipase‐secreting acinar cell carcinoma (2003) (10)
An unusual manifestation of linear scleroderma ‘en coup de sabre’ on the vertex and frontoparietal regions (2007) (10)
High levels of CCL26 in blister fluid and sera of patients with bullous pemphigoid. (2012) (10)
A case of kerion celsi due to Arthroderma benhamiae identified by DNA sequences of nuclear ribosomal internal transcribed spacer 1 regions. (2003) (10)
Heliotrope‐like eruption mimicking dermatomyositis in a patient treated with imatinib mesylate for chronic myeloid leukemia (2006) (10)
Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts. (2007) (10)
Necrobiotic xanthogranuloma with paraproteinemia successfully treated with melphalan, prednisolone and skin graft (2007) (10)
Diaper Dermatitis with Granuloma Following Surgery for Hirschsprung's Disease (1987) (10)
Antiubiquitin antibody in localised and systemic scleroderma. (1996) (10)
Seborrheic pemphigoid and polymorphic pemphigoid. (1991) (10)
Mycosis fungoides with recurrent Hodgkin's lymphoma and diffuse large B-cell lymphoma. (2009) (10)
Duration of remission period of narrowband ultraviolet B therapy on psoriasis vulgaris (2011) (10)
Increased serum concentration of hyaluronate in dermatomyositis patients (1998) (10)
Successful treatment of dermatomyositis with high-dose intravenous immunoglobulin. (2006) (9)
In‐vivo administration of recombinant IL‐2 increases the number of Thy‐1+ dendritic epidermal cells (1991) (9)
Epidermal growth factor up-regulates transforming growth factor-β receptor type II in human dermal fibroblasts via p38 mitogen-activated protein kinase pathway (2007) (9)
Lectin‐binding sites in eccrine sweat gland tumours (1986) (9)
Elevated circulating soluble CD40 ligand in patients with mixed connective tissue disease (2003) (9)
Balloon Cell Melanoma Cells in Metastatic Lesions from Pedunculated Malignant Melanoma (1995) (9)
Brown papules and leukoderma in Darier's disease: clinical and histological features. (1994) (9)
Amyopathic dermatomyositis associated with esophageal cancer (2008) (9)
Molecular mechanisms involved in the migration of epidermal dendritic cells in the skin. (1999) (9)
Patterns of basal cell keratin 14 expression in Bowen's disease: a possible marker for tumour progression (2001) (9)
Eccrine angiomatous hamartoma with massive mucin deposition. (2005) (9)
Distribution of anti‐p80‐coilin autoantibody in collagen diseaseand various skin diseases (1997) (9)
Circulating soluble CD40 ligand in patients with eosinophilic fasciitis (2003) (9)
Identification of an equivalent to murine Thy-1+ dendritic epidermal cells in the rat epidermis. (1992) (9)
Presence and distribution of carcinoembryonic antigen and lectin‐binding sites in benign apocrine sweat gland tumours (1985) (9)
Detection of human herpesvirus-6 transcripts in carbamazepine-induced hypersensitivity syndrome by in situ hybridization. (2009) (9)
Plasma plasmin-alpha2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertension. (2003) (9)
Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjögren's syndrome (2004) (9)
Serum matrix metalloproteinase-3 in systemic sclerosis (2004) (9)
THE EFFECT OF ULTRAVIOLET B IRRADIATION ON DELAYED‐TYPE HYPERSENSITIVITY, CYTOTOXIC T LYMPHOCYTE ACTIVITY, AND SKIN GRAFT REJECTION (1989) (8)
Immunosuppressive effects of azelastine hydrochloride on contact hypersensitivity and T-cell proliferative response: a comparative study with FK-506. (1994) (8)
Extensive tufted angioma of the left arm in a 47‐year‐old woman (2009) (8)
A Keratin 9 Gene Mutation (Asn160Ser) in a Japanese Patient with Epidermolytic Palmoplantar Keratoderma (2002) (8)
Blocking MAPK signaling downregulates CCL21 in lymphatic endothelial cells and impairs contact hypersensitivity responses. (2011) (8)
Improving Sun Protection Behaviour in Children: Study Design and Baseline Results of a Randomized Trial in Italian Elementary Schools (2003) (8)
Serum levels of soluble CD21 in patients with systemic sclerosis (2012) (8)
GENERALIZED ERUPTIVE SYRINGOMA (2005) (8)
Anti-U1RNP antibodies in patients with localized scleroderma (2001) (8)
Treatment of psoriasis vulgaris with narrow-band UVB and topical Maxacalcitol. (2006) (8)
Folliculotropic mycosis fungoides with severe hepatic failure due to hepatic involvement. (2009) (8)
Increased CCL1 levels in the sera and blister fluid of patients with bullous pemphigoid. (2009) (8)
Cell type‐specific regulation of the TGF‐β‐responsive α2(I) collagen gene by CpG methylation (2005) (8)
Four Primary Malignant Tumors, Including Malignant Melanoma and Malignant Lymphoma, in the Same Adult Patient (1987) (8)
Nuchal fibroma clearly visualized by computed tomography: a case report (2005) (7)
Effect of d-penicillamine on pulmonary fibrosis in patients with systemic sclerosis (2003) (7)
Keloidlike morphea. (1997) (7)
Epidermal and dermal gamma-delta T cells. (2001) (7)
Altered expression of NU-T2-BMZ antigen and type VII collagen in basal cell epithelioma. (1994) (7)
Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets 1 and Fli 1 (2005) (7)
ERK inhibitor PD98059 promotes the phenotypic and functional maturation of murine resident Langerhans cells (2007) (7)
Subcutaneous metastasis following percutaneous ethanol injection therapy for hepatocellular carcinoma. (2001) (7)
Cell type-specific regulation of the TGF-beta-responsive alpha2(I) collagen gene by CpG methylation. (2005) (7)
The role of lymphocytes in healthy and eczematous skin (2001) (7)
Lack of association of CCR3 single nucleotide polymorphism with atopic dermatitis in Japanese population. (2003) (7)
Roxithromycin downregulates production of CTACK/CCL27 and MIP-3α/CCL20 from epidermal keratinocytes (2010) (7)
Serum TARC/CCL17 levels are increased in dermatomyositis associated with interstitial lung disease. (2010) (7)
Comparison of prevalence of atopic dermatitis in Japanese elementary schoolchildren between 2001/2002 and 2007/2008 (2009) (7)
Pretibial Epidermolysis Bullosa: Successful Therapy With a Skin Graft (1986) (7)
Interesting response to concurrent chemoradiation in metastatic eccrine porocarcinoma (2008) (7)
Antinuclear and Antithyroid Antibodies in 68 Japanese Patients with Alopecia areata (1999) (7)
Activation pattern of Langerhans cells in the afferent and efferent phases of contact hypersensitivity. (1999) (7)
Proliferating tricholemmal cystic carcinoma: a case containing differentiated and dedifferentiated parts (2008) (7)
A Case of Subcutaneous Malignant Fibrous Histiocytoma Circumscribed by Fibrous Tissue (1996) (6)
Ultraviolet A irradiation inhibits thymus and activation-regulated chemokine (TARC/CCL17) production by a human keratinocyte HaCaT cell line. (2003) (6)
Dermatofibrosarcoma protuberans with COL1A1‐PDGFB fusion transcript arising on a scar due to a previous drainage tube insertion (2008) (6)
Prevalence in myositis of antibodies recognizing anti‐U3 RNA probably in a novel complex with 22/25 kD protein and not fibrillarin (2001) (6)
The involvement of Gab1 and PI 3‐kinase in β1 integrin signaling in keratinocytes (2007) (6)
Gene mutation analysis in five cases of dermatofibrosarcoma protuberans using formalin-fixed, paraffin-embedded tissues. (2005) (6)
Primary cutaneous CD30(Ki-1)-positive lymphoma of non-T, non-B origin. (1995) (6)
Focal palmoplantar callosities in non-Herlitz junctional epidermolysis bullosa. (2005) (6)
Long‐term Follow‐up Study of Onychomycosis: Cure Rate and Dropout Rate with Oral Antifungal Treatments (2001) (6)
A case of acute radiation syndrome from the dermatological aspect. (2008) (6)
Ligation of E-cadherin molecules on murine resident Langerhans cells inhibits their maturation and chemokine production. (2006) (6)
TGF-beta1-mediated regulation of thymus and activation-regulated chemokine (TARC/CCL17) synthesis and secretion by HaCaT cells co-stimulated with TNF-alpha and IFN-gamma. (2002) (6)
Labial melanotic macule diagnosed by dermoscopy. (2008) (6)
Psoriasis guttata in association with hepatocellular carcinoma. (2003) (6)
EPIDERMOLYSIS BULLOSA ACQUISITA DIAGNOSED BY IMMUNOELECTRON MICROSCOPY (1983) (6)
The direct action of 1alpha,25(OH)2-vitamin D3 on purified mouse Langerhans cells. (2007) (6)
046 TIMP-1 may be an autocrine growth factor in scleroderma fibroblasts (1997) (5)
Systemic sclerosis with an unusual rapid development of huge calcinosis (tumoral calcinosis) (2011) (5)
Dermal endothelial cells express eotaxin in hypereosinophilic syndrome. (2003) (5)
Bilateral segmental neurofibromatosis. (2002) (5)
A Case of Cutaneous Squamous Cell Carcinoma Associated with Sporadic Porphyria Cutanea Tarda Due to Liver Disorder after Schistosoma japonicum Infection (1991) (5)
Does Hermansky–Pudlak syndrome predispose to systemic lupus erythematosus? (2002) (5)
Psoriasis arthropathica associated with severe obesity showing high serum leptin level (2009) (5)
Topical Hydroquinone Treatment for Atopic Dirty Neck (2000) (5)
Mycosis fungoides associated with intestinal mucosa‐associated lymphoid tissue lymphoma (2004) (5)
A novel keratin 9 gene mutation (Met156Arg) in a Japanese patient with epidermolytic palmoplantar keratoderma (2006) (5)
Cutaneous reaction induced by vincristine (2005) (5)
Serum levels of manganese superoxide dismutase in patients with localized scleroderma (2004) (5)
Cicatricial Pemphigoid with Linear IgA Deposit (1990) (5)
A Keratin 10 Gene Mutation (Arg156Cys) in a Japanese Patient with Bullous Congenital Ichthyosiform Erythroderma (2002) (5)
Outbreak of staphylococcal scalded skin syndrome evaluated by DNA fingerprinting (1995) (5)
Serum anti-Fcγ receptor autoantibodies in patients with alopecia areata (2007) (5)
Therapeutic Guidelines for Atopic Dermatitis 2002 (2005) (5)
Pemphigus Vegetans Presenting as Scrotal Tongue (1989) (5)
Epithelioid Sarcoma Associated with Lung Adenocarcinoma (2005) (4)
[Panniculitis and interstitial pneumonitis in dermatomyositis]. (1987) (4)
Lipidized fibrous histiocytoma on the left condyle of the tibia (2011) (4)
Serum interleukin‐27 levels in patients with cutaneous T‐cell lymphoma (2010) (4)
Necrobiosis Lipoidica Diabeticorum Associated With Familial Hypo‐β‐lipoproteinemia (1987) (4)
Extramammary Paget’s disease with intracytoplasmic lumen formation (2009) (4)
Clinical significance of serum surfactant protein D ( SPD ) in patients with polymyositis u dermatomyositis : correlation with interstitial lung disease (2002) (4)
Bullous Pemphigoid of Childhood: Immunofluorescent Investigation (1988) (4)
Signaling through CD40 ligand decreases CD80 expression on murine Langerhans cells and enhances IL-12 p40 production. (2005) (4)
Differential expression of transforming growth factor‐β receptors in squamous cell carcinoma (2001) (4)
Successful treatment of Pyoderma gangrenosum with potassium iodide. (2006) (4)
Pseudoxanthomatous lesions with membranocystic changes of collagen fibers in an SLE patient receiving long-term steroid treatment. (1997) (4)
Chronic active EB virus infection complicated with IgG3 subclass deficiency: an adult case treated with intravenous immunoglobulin and IFN-alpha. (2003) (4)
Blue naevus with pigment network-like structure on dermoscopy. (2008) (4)
Elevated circulating soluble CD30 levels in patients with polymyositis/dermatomyositis (2001) (4)
Cetirizine hydrochloride suppresses the CCL17 production of epidermal keratinocytes and dermal fibroblasts (2012) (3)
Fibroblasts Signaling in Scleroderma b Autocrine TGF-Contributes to the Establishment of 3 b v a Increased Expression of Integrin (2005) (3)
Serum 5‐S‐cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy (2008) (3)
113 Characterization of a gc-rich region containing Sp1 binding site(S) as a constitutive responsive element of the α2(I) collagen gene in human fibroblasts (1995) (3)
Serum levels of tissue inhibitor of metalloproteinases in patients with mixed connective tissue disease. (2002) (3)
Cysteinyl leukotriene receptor 2 gene polymorphism ‐1220 A/C is not associated with atopic dermatitis or psoriasis vulgaris in Japanese patients (2011) (3)
Rosai-Dorfman disease presenting as large pigmented indurated plaques. (2003) (3)
Epidermal growth factor up-regulates transforming growth factor-beta receptor type II in human dermal fibroblasts via p38 mitogen-activated protein kinase pathway. (2007) (3)
Generalized morphea positive for anticentromere antibody. (2008) (3)
Detection of Hexanol Dehydrogenase Activity in the Epidermis of a Patient with Sjögren‐Larsson Syndrome (1992) (3)
Square‐shaped scleredema in the back: probably induced by mechanical stress (2005) (3)
Secondary cutaneous candidiasis with eosinophilia (2010) (3)
Autoimmune response to 52‐kDa and 60‐kDa Ro/SS‐A antigens in mixed connective tissue disease (2002) (3)
Elevated serum levels of manganese superoxide dismutase in patients with eosinophilic fasciitis (2003) (3)
Expression of CD44 antigen by Langerhans cells and Thy1+ dendritic epidermal cells--ontogenetic variation and its role in migration. (1995) (3)
Kimura's disease with prolonged history and prominent vascular involvement. (2005) (3)
A case of primary cutaneous anaplastic large cell lymphoma with prominent epidermotropism (2012) (3)
Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata. (2007) (3)
The development of Th1-mediated sarcoidosis improves the clinical course of Th2-mediated atopic dermatitis (2011) (3)
Serum levels of anti‐agalactosyl IgG antibodies in mixed connective tissue disease (2005) (2)
[T cell receptor gamma delta expression of Thy-1+ dendritic epidermal cells--an update]. (1990) (2)
Leukocytopenia after administration of itraconazole (2003) (2)
Retrospective study of clinical and laboratory features in Japanese scleroderma patients with cardiac involvement. (2009) (2)
Eosinophilic Pustular Folliculitis with a Butterfly Rash-Like Distribution (2004) (2)
A GRANULAR CELL TUMOR (1978) (2)
Differential enhancement of interferon‐γ‐induced MHC class II expression of HEp‐2 cells by 1,25‐dihydroxyvitamin D3 (1990) (2)
Anti‐p53 antibodies in patients with systemic sclerosis (2007) (2)
[Carcinoembryonic antigen and beta 2-microglobulin in genital Paget's disease]. (1983) (2)
Diffuse palmoplantar keratoderma associated with acrocyanosis and livedo reticularis. Two sporadic cases. (1995) (2)
A Case of Lichen Sclerosus et Atrophicus with Marked Fibrosis in the Dermis: Analysis of Fibrogenetic Cytokines by Reverse Transcriptase‐Polymerase Chain Reaction (2004) (2)
1,25-dihydroxyvitamin D3 decreases the interferon-γ induced HLA-DR expression but not intercellular adhesion molecule 1 on human keratinocytes (1991) (2)
ULTRASTRUCTURE OF MULTIPLE GLOMUS TUMORS (1978) (2)
Severe generalized pustular psoriasis accompanied by bullae formation with increased serum vascular endothelial growth factor level (2012) (2)
Interferon‐γ‐induced HLA‐DR, but not ICAM‐1, Expression of Human Keratinocytes Is Down‐regulated by Calmodulin Antagonist (1994) (2)
Severe hyperkeratotic palmoplantar eczema (eczema tyloticum) (2009) (2)
Epithelioid granulomas in post‐transplantation chronic graft‐vs.‐host disease (2003) (2)
Serum interleukin-15 levels are not elevated in patients with stage I and II mycosis fungoides. (2000) (2)
PNA‐binding Sites in Sebaceous Tumors (1987) (2)
Subpopulation of murine epidermal Langerhans cells identified by lectin-binding sites (2004) (2)
Constitutive phosphorylated Smad3 interacts with Sp1 and p300/CBP in scleroderma fibroblasts (2004) (1)
Tumour necrosis factor enhances the interferon-γ-induced class II MHC antigen expression on murine keratinocytes in vivo (2004) (1)
Research on Langerhans cells takes a new turn. (2000) (1)
Serum uric acid levels in patients with vitiligo receiving narrowband ultraviolet B phototherapy (2006) (1)
[Basement membrane zone antigens during epidermal wound healing--EBA antigen, BP antigen and fibronectin]. (1986) (1)
Psoriasis vulgaris associated with superior vena cava syndrome due to lung cancer metastasis (2007) (1)
Reagents inducing epidermal proliferation also induce pigmentation: induction of keratinocyte proliferation as a novel strategy for the treatment of vitiligo. (2013) (1)
Necrobiosis lipoidica diabeticorum associated with familial hypo-beta-lipoproteinemia. (1987) (1)
Differential regulation of CD40, B7-1 and B7-2 on purified epidermal Langerhans cells by cytokines and immunosuppressants (1998) (1)
Matrix metalloproteinase‐9 expression in desmoplastic melanoma (2008) (1)
Langerhans cells do not produce interferon-gamma. (2003) (1)
Functional CD40 ligand (CD40L) is expressed on cultured murine epidermal langerhans cells (1998) (1)
Pemphigoid vegetans (1989) (1)
Novel mutation (Asp158Val) in H1 domain of keratin 5 gene in a Japanese patient with Köbner‐type epidermolysis bullosa simplex (2006) (1)
The Lesional Skin of Linear IgA Bullous Dermatosis Expresses Growth‐Regulated Peptide (GRO)‐α (2004) (1)
[A female case of hyper-IgM immunodeficiency syndrome with uncommon skin manifestations]. (2004) (1)
A case of brain-invasive squamous cell carcinoma originating from a burn scar (2003) (1)
Increased Serum Levels of Circulating CD40 Ligand in Patients with Bullous Pemphigoid: Preliminary Results (2007) (1)
KERATINOCYTE APOPTOSIS ON TYPE I COLLAGEN GEL CAUSED BY A LACK OF LAMININ 5 AND 10/11 DEPOSITION (2002) (1)
The Spectrum of Photodamage and its Treatment (1995) (1)
Anaplastic large cell lymphoma associated with parapsoriasis en plaques. (2008) (1)
Detection of molluscum contagiosum virus gene transcripts by in situ hybridization. (2009) (1)
In Memoriam / Announcements (1999) (1)
Immunology of Langerhans Cells (1990) (0)
Migration of dendritic epidermal T cells (DETC): Ly48 and TNF-α are responsible for the migration of DETC to the epidermis in an in vitro organ culture model system (1993) (0)
Protein Kinase-Dependent Pathway Dermal Fibroblasts Via a Mitogen-Activated Oncostatin (2000) (0)
166 Expression of cutaneous lymphocyte — associated antigen on human Langerhans cells (1995) (0)
Dermatofibrosarcoma protuberans: Implication of multiple autocrine growth factor regulation (1998) (0)
[Immunohistochemical study of the distribution of blood group antigens A, B and H in tumors of the epidermis]. (1987) (0)
IL-13 UPREGULATES TENASCIN SYNTHESIS IN DERMAL FIBROBLASTS (2002) (0)
Systemic Autoimmunity and B10 Cell Deficiency Exacerbates Suppressive Role in Murine Lupus: CD19 Regulatory B Cells (B10 Cells) Have a (2010) (0)
Contents Vol. 207, 2003 (2004) (0)
INFLUENCE OF ROUTE ON THE INDUCTION AND PERSISTENCE OF DELAYED TYPE HYPERSENSITIVITY TO ALLOANTIGENS (1985) (0)
Contents Vol. 210, 2005 (2005) (0)
Expression of tetra-spans transmembrane family in skin, oral mucosa and esophagus (1998) (0)
P864 - Analysis of HLA class II, TAP and HLA-DM genes in Japanese patients with atopic dermatitis (1996) (0)
Selective regulation of surface expression of MHC class I, MHC class II, and ICAM-1 in Langerhans cells by various cytokines (1994) (0)
Erratum / Book Review (2001) (0)
Distinctive tyrosine phosphorylation pattern of CD19 during BCR and CD40 signaling (2008) (0)
Case of the malignant melanoma developed in multiple and collective phase of the congenital mole. (1996) (0)
[Atopic dermatitis]. (2011) (0)
A case of Angiosarcoma not recognizing metastasis for about 3 year by IL-2 administration. (1997) (0)
003 Chronologcal analysis of in situ cytokine expression in mite-allergen induced dermatitis inatopic subjects (1995) (0)
Antiubiquitin antibody inlocalised andsystemic scleroderma (1996) (0)
Microtubule is involved in the expression of vascular cell adhesion molecule-1 (VCAM-1) (1998) (0)
{alpha}4{beta}7 integrin is essential for contact hypersensitivity by regulating migration of T cells to inflammatory skin. (2010) (0)
2 IL-1, but not TNF-α, synergistically up-regulates the GM-CSF-induced B7-1 expression of murine langerhans cells (1996) (0)
A Male Case of Systemic Sclerosis with Anti Th/To Antibody (2001) (0)
ReactionsRemission Phase of Contact Hypersensitivity Functions of Peritoneal B-1a Cells during the CD22 Expression Mediates the Regulatory (2010) (0)
Distinct Regulation of Individual Tyrosine Phosphorylation of the Cytoplasmic Domain of CD19 (2007) (0)
Contents, Vol. 111, Supplement 1, 1996 (1996) (0)
091 Regulatory function of M-CSF, GM-CSF and TNF-α on the expression of costimulatory molecules of murine epidermal langerhans cells (LC) (1997) (0)
Accessory and adhesion molecules expressed on murine epidermal Langerhans cells and the modulation by cytokines. (1999) (0)
[Carcinoembryonic antigen in genital Paget's disease]. (1985) (0)
Serum Levels of Type 2 Chemokines in Lepromatous Leprosy Patients (2002) (0)
082 Modulaticn of cell adhesion molecules by griseofulvin (1997) (0)
Epidermal TGF- β 2 and MCP (monocyte chemoattractant protein) - 1 positivity correlates with CLA (cutaneous lymphocyte associated antigen) positive Langerhans cell numbers. (1996) (0)
164 The expression of connective tissue growth factor during wound healing (1997) (0)
Constitutive Thrombospondin-1 Overexpression Contributes to the Autocrine TGF-β Signaling in Cultured Scleroderma Fibroblasts (2006) (0)
Atopic Dermatitis and Chemokine (2008) (0)
Expression of CD44 in epidermal Langerhans cells -ontogeny and modulation by various cytokines and immunosuppressive drugs- (1994) (0)
177 Differential and dynamic behavior of epidermal Langerhans cells in afferent phase or in efferent phase of contact hypersensitivity (1995) (0)
093 Ontogeny of TCR αgb+ and γδ+ cells in the murine fetal skin (1997) (0)
The effects of mechanical stretch on keratinocytes (2005) (0)
Acknowledgment to Referees for Dermatology 1998 (1998) (0)
108 Human kerationocytes express the C-terminal domain of dystrophin in the desmosomal attachment plaques (1996) (0)
Langerhans cell-containing epidermal cells are not cytotoxic in antibody-dependent- and mitogen-induced-cellular cytotoxicity. (1982) (0)
Scanning electron microscopic and X-ray microanalytic studies of hair, nail and follicular keratotic papule in pachyonychia congenita (1993) (0)
Case of giant pigmented nevus causing squamous cell carcinoma by irradiation. (1998) (0)
Langerhans cells and delayed-type allergy. (1988) (0)
Serum levels of manganese superoxide dismutase in patients with mixed connective tissue disease. (2005) (0)
Crystals Inflammatory Responses Induced by Receptor Signaling Pathway Mediates 6 P2Y (0)
A case of malignant melanoma of unknown origin with skin metastasis of achromasia. (1991) (0)
Clinical study of cyclosporin therapy on psoriasis: comparative study between long-term countinuous and intermittent administration (1998) (0)
047 Connective tissue growth factor gene expression in tissue sections from eosinofhilic fasciitis (1997) (0)
Inhibition of contact hypersensitivity by an anti-allergic drug, azelastine, is likely to be mediated by its novel immunosuppressive effects distinct from FK-506 (1993) (0)
C-C chemokines, RANTES, MCP-3, and MIP-1α, selectively up-regulate the IL-5 production by atopic CD4+ T cells in the presence of fibronectin (1998) (0)
Langerhans Cells Factor Inhibits IL-12 production of Mouse Granulocyte/Macrophage Colony-Stimulating (2000) (0)
P108 Clinical study of cyclosporin therapy on psoriasis: Comparative study between long-term continuous and interment therapies. The report on fourth-year results (1997) (0)
mechanical stretch, signal transduction, EGF receptor, MAP kinase (2005) (0)
Subject Index Vol. 207, 2003 (2003) (0)
Expression of type VII collagen and NU-T2-BMZ antigen in various skin tumors (1992) (0)
Identification of CD3+ T cell receptor αβ− dendritic pidermal cells in rat epidermis — An equivalent of murine Thy-1+ dendritic epidermal cells (1990) (0)
Platelet-activating factor receptor is expressed on human melanoma cells and platelet-activating factor enhanced melanoma cell growth (1998) (0)
Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid Increased serum APRIL levels in bullous pemphigoid (2007) (0)
[The role of dendritic cells in eczema and dermatitis]. (2002) (0)
Chemotaxis in immunity (WS-029) Chairpersons: Osamu Yoshie, Naofumi Mukaida (2010) (0)
P15 Analysis of HLA class II, TAP and HLA-DM genes in Japanese patients with atopic dermatitis (1996) (0)
010 Estrogen enhances immunoglubulin production by human peripheral blood mononuclear cells (1996) (0)
Decreased growth response to endothelin-1 in scleroderma fibroblasts (1994) (0)
A case of epithelioid sarcoma arose in the head. (1997) (0)
α4β7 integrin is essential for contact hypersensitivity by regulating migration of T cells to inflammatory skin. (44.11) (2010) (0)
insufficiency fracture with rapid collapse of the femoral head in a patient with Turner ’ s syndrome (2005) (0)
Statistical observation of cutaneous malignant melanoma at the Department of Derinatology, University of Tokyo for twelve years. (2000) (0)
Paraneoplastic Pemphigus Presenting with Prominent Lichanoid Tissue Reaction (2001) (0)
181 Effect of estrogen on the growth of cultured neurofibroma cells (1996) (0)
Subject Index Vol. 210, 2005 (2005) (0)
Upregulated Tenascin-C Expression in Stroma around Basal Cell Carcinoma;Induction by Interleukin-13 in Human Dermal Fibroblasts via PI3-K/Akt and PKC pathway (2003) (0)
and Scleroderma Fibroblasts 2(I) Collagen Gene Expression in Normal a Phosphatidylinositol 3-Kinase Is Involved in (2004) (0)
Griseofulvin decreases the interferon- γ (IFN- γ) induced HLA-drexpression but not intercellular adhesion molecule-1 (ICAM-1) on human keratinocytes (1992) (0)
Diagnosis of Epidermolytic Palmoplantar Keratoderma in a Very Early Stage by Gene Analysis (2005) (0)
PhosphorylationDifferentially Regulate CD22 Tyrosine B Cell Antigen Receptor and CD40 (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Kunihiko Tamaki?

Kunihiko Tamaki is affiliated with the following schools:

University of Tokyo

Kunihiko Tamaki's Academic­Influence.com Rankings

Kunihiko Tamaki's Degrees

Why Is Kunihiko Tamaki Influential?

Kunihiko Tamaki's Published Works

Published Works

What Schools Are Affiliated With Kunihiko Tamaki?

Kunihiko Tamaki's AcademicInfluence.com Rankings